Yoon Jin Choi1,2, Dong Ho Lee1,3, Dong Woo Shin1, Kyung-Do Han4, Hyuk Yoon1, Cheol Min Shin1, Young Soo Park1, Nayoung Kim1,3. 1. Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea. 2. Department of Internal Medicine, Korea University Guro Hospital, Seoul, South Korea. 3. Department of Internal Medicine, Liver Research Institute, Seoul National University College of Medicine, Seoul, South Korea. 4. Department of Biostatistics, College of Medicine, The Catholic University of Korea, Seoul, South Korea.
Abstract
BACKGROUND: Inflammatory bowel disease (IBD) is accompanied by various extraintestinal manifestations including systemic inflammation and hypercoagulability, which may increase the risk of atherosclerosis and ischaemic heart disease. AIM: To investigate whether IBD is associated with an increased risk of myocardial infarction (MI), stroke or death METHODS: The International Classification of Disease, 10th edition codes and the claim codes for rare diseases were used to identify candidates from National Health Insurance Service (NHIS) of South Korea. Patients diagnosed with Crohn's disease (CD) or ulcerative colitis (UC) between 2006 and 2009 were age-matched 1:3 with NHIS enrolees without IBD. The primary outcomes included newly developed MI, stroke and death. Hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated using Cox regression models. RESULTS: We identified 10 708 patients diagnosed with CD and 26 769 with UC. MI risk was higher in CD patients than in controls (incidence ratio (IR) 1.64 per 1000 person-years, HR, 1.80; 95% CI, 1.47-2.21), and this trend was more prominent among patients aged <40 years (IR 0.69 per 1000 person-years, HR, 2.96; 95% CI, 1.96-4.47) and among female patients (IR 2.35 per 1000 person-years, HR, 2.18; 95% CI, 1.61-2.94). In contrast, only female patients with UC had an increased risk of MI (IR 2.01 per 1000 person-years, HR, 1.33; 95% CI, 1.13-1.56). CONCLUSIONS: The risk of MI risk is higher in patients with CD than in the general population, and this trend is stronger in female patients and those aged <40 years.
BACKGROUND:Inflammatory bowel disease (IBD) is accompanied by various extraintestinal manifestations including systemic inflammation and hypercoagulability, which may increase the risk of atherosclerosis and ischaemic heart disease. AIM: To investigate whether IBD is associated with an increased risk of myocardial infarction (MI), stroke or death METHODS: The International Classification of Disease, 10th edition codes and the claim codes for rare diseases were used to identify candidates from National Health Insurance Service (NHIS) of South Korea. Patients diagnosed with Crohn's disease (CD) or ulcerative colitis (UC) between 2006 and 2009 were age-matched 1:3 with NHIS enrolees without IBD. The primary outcomes included newly developed MI, stroke and death. Hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated using Cox regression models. RESULTS: We identified 10 708 patients diagnosed with CD and 26 769 with UC. MI risk was higher in CDpatients than in controls (incidence ratio (IR) 1.64 per 1000 person-years, HR, 1.80; 95% CI, 1.47-2.21), and this trend was more prominent among patients aged <40 years (IR 0.69 per 1000 person-years, HR, 2.96; 95% CI, 1.96-4.47) and among female patients (IR 2.35 per 1000 person-years, HR, 2.18; 95% CI, 1.61-2.94). In contrast, only female patients with UC had an increased risk of MI (IR 2.01 per 1000 person-years, HR, 1.33; 95% CI, 1.13-1.56). CONCLUSIONS: The risk of MI risk is higher in patients with CD than in the general population, and this trend is stronger in female patients and those aged <40 years.
Authors: Yanbo Tang; Kevin T Kline; Xiaoying S Zhong; Ying Xiao; Haifeng Lian; Jun Peng; Xiaowei Liu; Don W Powell; Guodu Tang; Qingjie Li Journal: PLoS One Date: 2021-09-20 Impact factor: 3.752
Authors: Vera E R Asscher; Vince B C Biemans; Marieke J Pierik; Gerard Dijkstra; Mark Löwenberg; Sander van der Marel; Nanne K H de Boer; Alexander G L Bodelier; Jeroen M Jansen; Rachel L West; Jeoffrey J L Haans; Willemijn A van Dop; Rinse K Weersma; Frank Hoentjen; P W Jeroen Maljaars Journal: Aliment Pharmacol Ther Date: 2020-09-09 Impact factor: 8.171
Authors: Scott McHenry; Ankita Tirath; Richard Tsai; Yeshika Sharma; Avegail G Flores; Nicholas O Davidson; Kathryn J Fowler; Matthew A Ciorba; Parakkal Deepak Journal: Inflamm Bowel Dis Date: 2020-11-19 Impact factor: 5.325